US021 — Washington D.C., District of Columbia

US021 is a clinical research site located in Washington D.C., District of Columbia, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

US021 has participated in 1 clinical trials.

Therapeutic areas: Schizophrenia.

Sponsors: H. Lundbeck A/S.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US021?

US021 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US021 conducted?

US021 has 1 clinical trials on record. Their work covers Schizophrenia.

Is US021 accredited by Crixeo Health?

US021 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US021?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.